Nuveen Asset Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $27M | Buy |
527,792
+13,598
| +3% | +$695K | 0.01% | 984 |
|
|
2024
Q3 | $26.3M | Buy |
514,194
+51,428
| +11% | +$2.63M | 0.01% | 998 |
|
|
2024
Q2 | $20.7M | Sell |
462,766
-90,973
| -16% | -$4.07M | 0.01% | 1106 |
|
|
2024
Q1 | $25.9M | Sell |
553,739
-125,432
| -18% | -$5.87M | 0.01% | 1012 |
|
|
2023
Q4 | $24.2M | Buy |
679,171
+268,230
| +65% | +$9.54M | 0.01% | 1032 |
|
|
2023
Q3 | $12.2M | Buy |
410,941
+67,762
| +20% | +$2.02M | ﹤0.01% | 1355 |
|
|
2023
Q2 | $6.18M | Buy |
343,179
+218,870
| +176% | +$3.94M | ﹤0.01% | 1791 |
|
|
2023
Q1 | $2M | Sell |
124,309
-13,384
| -10% | -$215K | ﹤0.01% | 2330 |
|
|
2022
Q4 | $2.52M | Sell |
137,693
-158,898
| -54% | -$2.91M | ﹤0.01% | 2280 |
|
|
2022
Q3 | $5.83M | Sell |
296,591
-105,419
| -26% | -$2.07M | ﹤0.01% | 1812 |
|
|
2022
Q2 | $7.5M | Buy |
402,010
+104,885
| +35% | +$1.96M | ﹤0.01% | 1696 |
|
|
2022
Q1 | $5.65M | Buy |
297,125
+1,613
| +0.5% | +$30.7K | ﹤0.01% | 1990 |
|
|
2021
Q4 | $7.16M | Buy |
295,512
+174,456
| +144% | +$4.23M | ﹤0.01% | 1889 |
|
|
2021
Q3 | $2.76M | Sell |
121,056
-27,293
| -18% | -$622K | ﹤0.01% | 2523 |
|
|
2021
Q2 | $2.8M | Buy |
148,349
+18,842
| +15% | +$355K | ﹤0.01% | 2549 |
|
|
2021
Q1 | $1.98M | Sell |
129,507
-7,655
| -6% | -$117K | ﹤0.01% | 2626 |
|
|
2020
Q4 | $1.94M | Sell |
137,162
-42,505
| -24% | -$600K | ﹤0.01% | 2526 |
|
|
2020
Q3 | $2.82M | Buy |
179,667
+23,095
| +15% | +$362K | ﹤0.01% | 2215 |
|
|
2020
Q2 | $2.74M | Buy |
156,572
+128,522
| +458% | +$2.25M | ﹤0.01% | 2200 |
|
|
2020
Q1 | $413K | Sell |
28,050
-191
| -0.7% | -$2.81K | ﹤0.01% | 2833 |
|
|
2019
Q4 | $709K | Sell |
28,241
-299
| -1% | -$7.51K | ﹤0.01% | 2806 |
|
|
2019
Q3 | $429K | Sell |
28,540
-1,166
| -4% | -$17.5K | ﹤0.01% | 2990 |
|
|
2019
Q2 | $742K | Buy |
+29,706
| New | +$742K | ﹤0.01% | 2860 |
|